During the past decade, Confluence Health conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Confluence Health" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Comprehensive Cancer Network" with 1 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Confluence Health" are "Atrial Fibrillation" (1 trials), "Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8" (1 trials), "Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8" (1 trials), "Locally Advanced Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Locally Advanced Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Confluence Health" in a lesser frequency.

Most popular intervention types in "Confluence Health" are "Behavioral" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Best Practice" (1 trials). Other intervention names were less common.

The vast majority of trials in "Confluence Health" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Confluence Health". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Confluence Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Confluence Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".